Hartmut Döhner Selected Research

Hartmut Döhner Research Topics

Disease

116	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 07/2003
61	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 08/2002
50	Neoplasms (Cancer) 01/2023 - 09/2002
44	Leukemia 11/2023 - 04/2002
13	Infections 11/2023 - 04/2005
11	Disease Progression 11/2020 - 11/2002
10	Neutropenia 02/2024 - 04/2005
10	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2023 - 05/2006
10	Residual Neoplasm 01/2023 - 10/2004
9	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 04/2005
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2007 - 09/2002
6	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 01/2004
6	Acute Promyelocytic Leukemia 11/2019 - 02/2009
5	Febrile Neutropenia 12/2023 - 01/2020
4	Thrombocytopenia (Thrombopenia) 02/2024 - 01/2020
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 09/2006
4	Multiple Myeloma 01/2022 - 07/2003
4	Lymphoma (Lymphomas) 02/2021 - 03/2003
4	Carcinogenesis 01/2017 - 01/2013
4	Melanoma (Melanoma, Malignant) 05/2013 - 09/2002
4	Hodgkin Disease (Hodgkin's Disease) 05/2012 - 04/2006
3	Pneumonia (Pneumonitis) 12/2023 - 11/2021
3	Pathologic Complete Response 07/2023 - 12/2005
3	Hemorrhage 01/2022 - 02/2009
3	Lymphadenopathy 05/2008 - 08/2004
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 07/2007 - 08/2004
3	Breast Neoplasms (Breast Cancer) 03/2007 - 09/2002
2	Thrombotic Microangiopathies 03/2024 - 12/2017
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2023 - 02/2006
2	Sepsis (Septicemia) 07/2023 - 04/2005
2	COVID-19 01/2023 - 01/2022
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021 - 01/2013
2	Trisomy (Trisomies) 01/2020 - 01/2004

Drug/Important Bio-Agent (IBA)

18	Azacitidine (5 Azacytidine)FDA Link 02/2024 - 07/2015
16	fludarabineIBA 01/2022 - 08/2004
15	Rituximab (Mabthera)FDA Link 01/2022 - 09/2011
15	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2005
15	AntigensIBA 01/2019 - 09/2002
11	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023 - 01/2009
11	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 03/2003
11	NucleophosminIBA 01/2019 - 12/2005
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 02/2006
10	MicroRNAs (MicroRNA)IBA 01/2020 - 02/2011
8	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2024 - 03/2007
8	midostaurinIBA 01/2022 - 01/2017
8	Core Binding Factors (Core-Binding Factor)IBA 12/2020 - 08/2007
7	venetoclaxIBA 02/2024 - 03/2014
7	Messenger RNA (mRNA)IBA 04/2013 - 09/2002
6	Decitabine FDA Link 12/2023 - 03/2012
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2008
5	Lenalidomide (CC 5013)FDA Link 01/2022 - 03/2013
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2005
5	Immunoglobulins (Immunoglobulin)IBA 11/2020 - 08/2002
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2023 - 08/2010
4	Gemtuzumab (Mylotarg)FDA Link 07/2023 - 01/2016
4	obinutuzumabIBA 01/2023 - 03/2014
4	Phosphotransferases (Kinase)IBA 01/2022 - 03/2013
4	EnzymesIBA 01/2021 - 08/2005
4	Bendamustine Hydrochloride FDA Link 02/2020 - 09/2011
4	Arsenic Trioxide (Trisenox)FDA Link 11/2019 - 02/2009
4	Peptides (Polypeptides)IBA 01/2014 - 08/2005
4	Alemtuzumab (Campath)FDA Link 08/2013 - 09/2006
4	CCAAT-Enhancer-Binding Protein-alphaIBA 02/2011 - 02/2004
4	Imatinib Mesylate (Gleevec)FDA Link 11/2007 - 12/2006
4	Hyaluronic Acid (Hyaluronan)IBA 06/2007 - 09/2002
3	enasidenibIBA 12/2023 - 01/2021
3	ibrutinibIBA 01/2023 - 01/2018
3	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2022 - 02/2006
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 05/2008
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
3	ivosidenibIBA 01/2022 - 01/2021
3	Protein Isoforms (Isoforms)IBA 01/2020 - 03/2013
3	Valproic Acid (Depakote)FDA LinkGeneric 01/2020 - 06/2014
3	Dasatinib (BMS 354825)FDA Link 01/2018 - 10/2008
3	Chlorambucil (Leukeran)FDA Link 06/2014 - 10/2009
3	NF-kappa B (NF-kB)IBA 04/2013 - 11/2002
2	guadecitabineIBA 01/2024 - 12/2023
2	palbociclibIBA 05/2023 - 01/2022
2	InterferonsIBA 01/2023 - 01/2014
2	VaccinesIBA 01/2023 - 08/2005
2	Immunomodulating AgentsIBA 01/2022 - 01/2017
2	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2021 - 01/2021
2	BI 6727IBA 08/2021 - 08/2014
2	Circular RNAIBA 01/2021 - 12/2017
2	Monoclonal AntibodiesIBA 01/2021 - 02/2006
2	fms-Like Tyrosine Kinase 3IBA 10/2020 - 01/2020
2	Histone Deacetylase InhibitorsIBA 01/2020 - 07/2016
2	Thymidine KinaseIBA 01/2020 - 01/2018

Therapy/Procedure

55	Therapeutics 12/2023 - 09/2002
41	Drug Therapy (Chemotherapy) 02/2024 - 08/2002
29	Stem Cell Transplantation 03/2024 - 04/2002
11	Immunotherapy 04/2020 - 09/2002
10	Hematopoietic Stem Cell Transplantation 10/2022 - 12/2006
6	Transplantation 03/2024 - 01/2016
6	Induction Chemotherapy 12/2023 - 11/2005
5	Cell Transplantation 07/2023 - 02/2008
4	Salvage Therapy 11/2019 - 02/2009
2	Radioimmunotherapy 07/2023 - 04/2002
2	Precision Medicine 11/2022 - 03/2017
2	Aftercare (After-Treatment) 01/2020 - 01/2016